HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 727675Generated: October 26, 2026
1-(2-Hydroxyethyl)piperazine → (2S,4R)-2-[4-(2-Hydroxyethyl)-1-piperazinylcarbonyl]-4-methanesulfonyloxy-1-(4-nitrobenzyloxy-carbonyl)pyrrolidine
https://huagongshe.com/reaction/727675
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1-(2-Hydroxyethyl)piperazine | HCID 7677 | — |
| Reactant | trans-4-methanesulfonyloxy-1-(4-nitrobenzyloxycarbonyl)-L-proline | HCID 13502650 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Product | (2S,4R)-2-[4-(2-Hydroxyethyl)-1-piperazinylcarbonyl]-4-methanesulfonyloxy-1-(4-nitrobenzyloxy-carbonyl)pyrrolidine | HCID 86752003 | 62.2% |
Reaction Steps
584 mg of N,N'-carbonyldiimidazole were added to a solution of 1.16 g of trans-4-methanesulfonyloxy-1-(4-nitrobenzyloxycarbonyl)-L-proline in 10 ml of dry acetonitrile, and the resulting mixture was stirred at 40° C. for 1 hour. 586 mg of 1-(2-Hydroxyethyl)piperazine were then added to the mixture, whilst ice-cooling, and the resulting mixture was stirred at the same temperature for 35 minutes. The solvent was then removed by distillation under reduced pressure, and the residue was purified in a similar manner so that described in step 54(a)(ii), to give 930 mg of the title compound, as a powder. The infrared absorption spectrum and nuclear magnetic resonance spectrum of the product were identical with those of the compound obtained as described in step 54(a)(ii) above.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05712267 |
|---|
| Source dataset | uspto-grants-1998_01 |
|---|
| ORD ID | ord-78ffc6ac7b54482e84477412d8c85c16 |
|---|
| Source note | uspto-grants-1998_01 |
|---|